0001493152-22-036085.txt : 20221221 0001493152-22-036085.hdr.sgml : 20221221 20221221090008 ACCESSION NUMBER: 0001493152-22-036085 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20221221 FILED AS OF DATE: 20221221 DATE AS OF CHANGE: 20221221 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EQONEX Ltd CENTRAL INDEX KEY: 0001790515 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 000000000 STATE OF INCORPORATION: U0 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39600 FILM NUMBER: 221476643 BUSINESS ADDRESS: STREET 1: 118 PICCADILLY CITY: MAYFAIR, LONDON STATE: X0 ZIP: W1J 7NW BUSINESS PHONE: 44 (0) 2034 050440 MAIL ADDRESS: STREET 1: 118 PICCADILLY CITY: MAYFAIR, LONDON STATE: X0 ZIP: W1J 7NW FORMER COMPANY: FORMER CONFORMED NAME: Diginex Ltd DATE OF NAME CHANGE: 20191231 FORMER COMPANY: FORMER CONFORMED NAME: Digital Innovative Ltd DATE OF NAME CHANGE: 20191007 6-K 1 form6-k.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

Pursuant to Rule 13a-16 or 15d-16 of the

Securities Exchange Act of 1934

For the month of December 2022

Commission File Number: 001-39600

EQONEX LIMITED

(Interim Judicial Managers Appointed)

(Translation of registrant’s name into English)

c/o Quantuma (Singapore) Pte Ltd

137 Amoy Street, 02-03 Far East Square

049965

Singapore

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

EXHIBIT INDEX

Exhibit No.		Description

99.1		Press Release: Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	EQONEX Limited (Interim Judicial Managers Appointed)

Date: December 21, 2022	By:	/s/ Luke Anthony Furler
	Name:	Luke Anthony Furler
	Title:	Joint and Several Interim Judicial Manager

EX-99.1 2 ex99-1.htm

Exhibit 99.1

EQONEX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

Singapore – December 21, 2022: As announced on July 26, 2022, EQONEX Limited (NASDAQ: EQOS) (“EQONEX” or the “Company”) (Interim Judicial Managers Appointed) received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) on July 21, 2022 that the Company was not in compliance with Listing Rule 5550(a)(2) as the bid price of the Company’s listed securities had closed at less than US$1.00 per share over the last 30 consecutive business days from June 7, 2022 to July 20, 2022. In accordance with Listing Rule 5810(c)(3)(A), the Company was provided 180 calendar days, or until January 17, 2023, to regain compliance with Listing Rule 5550(a)(2).

On December 19, 2022, the Company received another notice from Nasdaq that for the past 13 consecutive trading days, the closing bid price of the Company’s common stock has been below $0.10. Accordingly, pursuant to Listing Rule 5810(c)(3)(A)(iii), this matter serves as an additional basis for delisting the Company’s securities from Nasdaq.

The Company will present its views with respect to this additional deficiency at its hearing with the Nasdaq Hearings Panel. The Company intends to monitor the closing bid price of its ordinary shares and may, if appropriate, consider implementing available options, including, but not limited to, implementing a reverse share split of its outstanding ordinary shares, to regain compliance with the minimum bid price requirement under the Nasdaq Listing Rules for continued listing on Nasdaq.

For investor and media inquiries, please contact:

Investor Relations at ir@eqonex.com